SCHEMBL3504293

SCHEMBL3504293

CCCCCCC/C=C/C(=O)OCCCC

nearest known ligand 0.68

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.68
HCAR2 Q8TDS4 3/20 0.61
HPGD P15428 1/20 0.53
TSHR P16473 1/20 0.53
MAPT P10636 2/20 0.51
RAB9A P51151 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
FAAH O00519 1/20 0.50
APP P05067 4/20 0.49
PPARG P37231 2/20 0.49
PPARA Q07869 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8982887 1.00 ATM (0.68) ATMHCAR2HPGDTSHRMAPT
SCHEMBL8982892 1.00 ATM (0.68) ATMHCAR2HPGDTSHRMAPT
SCHEMBL29521300 1.00 ATM (0.68) ATMHCAR2HPGDTSHRMAPT
SCHEMBL28496178 1.00 ATM (0.68) ATMHCAR2HPGDTSHRMAPT
SCHEMBL858499 1.00 ATM (0.68) ATMHCAR2HPGDTSHRMAPT
SCHEMBL4235639 1.00 ATM (0.68) ATMHCAR2HPGDTSHRMAPT
SCHEMBL30913840 1.00 ATM (0.68) ATMHCAR2HPGDTSHRMAPT
SCHEMBL10481293 0.98 ATM (0.70) ATMHCAR2HPGDTSHRMAPT
SCHEMBL10481292 0.98 ATM (0.70) ATMHCAR2HPGDTSHRMAPT
SCHEMBL10857755 0.96 HCAR2 (0.66) ATMHCAR2MAPTFAAHAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3809876-A1 PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME PERPRIN S.R.L. (IT) 2021-04-28 EP claimed
WO-2019243869-A1 PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME PERPRIN S.R.L. (IT) 2019-12-26 WO claimed
WO-2009131692-A1 SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2009-10-29 WO claimed
US-20250302014-A1 WASP PEST MANAGEMENT SYSTEM TONER DARADH (IE) 2025-10-02 US disclosed
EP-4518647-A1 WASP PEST MANAGEMENT SYSTEM Toner, Daradh (IE) 2025-03-12 EP disclosed
US-20240108040-A1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2024-04-04 US disclosed
WO-2023214095-A1 WASP PEST MANAGEMENT SYSTEM TONER DARADH (IE) 2023-11-09 WO disclosed
EP-3416729-B1 PRO-FRAGRANCE COMPOSITION AQDOT LTD (GB) 2023-09-20 EP disclosed
US-11758933-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2023-09-19 US disclosed
CN-110891615-B System and method for selecting and releasing fragrance 阿甘香气及精细化学有限公司 2022-08-05 CN disclosed
EP-3368542-B1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2022-06-22 EP disclosed
US-20130296426-A1 ANALGESIC NAGOYA INDUSTRIAL SCIENCE RESEARCH INSTITUTE (JP) 2013-11-07 US disclosed
US-20130296425-A1 PROPHYLACTIC OR THERAPEUTIC AGENT FOR A PERIPHERAL NERVE DISORDER INDUCED BY ANTI-CANCER AGENTS NAGOYA INDUSTRIAL SCIENCE RESEARCH INSTITUTE (JP) 2013-11-07 US disclosed
US-20130296425-A1 PROPHYLACTIC OR THERAPEUTIC AGENT FOR A PERIPHERAL NERVE DISORDER INDUCED BY ANTI-CANCER AGENTS NAGOYA INDUSTRIAL SCIENCE RESEARCH INSTITUTE (JP) 2013-11-07 US disclosed
US-8539631-B2 Roller for providing benefits to fabric THE PROCTER & GAMBLE COMPANY (US) 2013-09-24 US disclosed
US-20100248390-A1 COMPOSITIONS AND METHODS FOR IDENTIFYING LIGANDS OF ODORANT RECEPTORS DUKE UNIVERSITY (US) 2010-09-30 US disclosed
WO-2009131692-A1 SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2009-10-29 WO disclosed
EP-1765139-A1 ROLLER FOR PROVIDING BENEFITS TO FABRIC The Procter and Gamble Company (US) 2007-03-28 EP disclosed
WO-2006010087-A1 ROLLER FOR PROVIDING BENEFITS TO FABRIC THE PROCTER & GAMBLE COMPANY (US) 2006-01-26 WO disclosed
US-20060005333-A1 Roller for providing benefits to fabric PROCTER & GAMBLE COMPANY, THE 2006-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108040-A1 HIGH INTENSITY SWEETENERS TAS2R40, TAS2R60, TAS1R1 ATM 322/4885HCAR2 2574/4885HPGD 1096/4885
US-20130296425-A1 PROPHYLACTIC OR THERAPEUTIC AGENT FOR A PERIPHERAL NERVE DISORDER INDUCED BY ANTI-CANCER AGENTS ALOX5, CPT1B, PMP22 ATM 4591/4885HCAR2 275/4885HPGD 361/4885
US-20130296426-A1 ANALGESIC CNTN1, SHARPIN, HCAR2 ATM 4872/4885HCAR2 3/4885HPGD 125/4885
US-11758933-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 ATM 322/4885HCAR2 2574/4885HPGD 1096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.